La chaîne d'options affiche les données clés des options sur actions de Repare Therapeutics à différents prix d'exercice et dates d'expiration. Les traders utilisent ces informations pour analyser les transactions potentielles et évaluer le sentiment du marché pour Repare Therapeutics..

Repare Therapeutics (NASDAQ:RPTX) Stock, Chaîne d'Options

REPARE THERAPEUTICS INC

Repare Therapeutics

Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.

Repare Therapeutics Inc

Citigroup analyst Andrew Baum downgrades Merck &amp; Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MRK#NYSE">MRK</a>) from Buy to Neutral and lowers the price target from $115 to $84.

News

Downgrades

Price Target

Analyst Ratings

Citigroup Downgrades Merck & Co to Neutral, Lowers Price Target to $84

Management

GRRR

Gorilla Technology Group Appoints Bruce Bower As CFO

Kala Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KALA#NASDAQ">KALA</a>) reported quarterly losses of $(1.41) per share which beat the analyst consensus estimate of $(2.03) by 30.54 percent. This is a 66.43 percent increase over losses of $(4.20) per share from the same period last year.

Earnings

Earnings Beats

KALA

Kala Bio Q1 EPS $(1.41) Beats $(2.03) Estimate

Indaptus Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INDP#NASDAQ">INDP</a>) reported quarterly losses of $(0.32) per share which missed the analyst consensus estimate of $(0.18) by 77.78 percent. This is a 28.89 percent increase over losses of $(0.45) per share from the same period last year.

Earnings Misses

INDP

Indaptus Therapeutics Q1 EPS $(0.32) Misses $(0.18) Estimate

Biotech

General

IXHL

Incannex Healthcare Completes Patient Dosing In Phase 2 Portion Of Phase 2/3 RePOSA Study Of IHL-42X In Obstructive Sleep Apnea

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul class="wp-block-list">
<li>Jefferies analyst Philippe Houchois downgraded the rating for Rivian Automotive, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIVN#NASDAQ">RIVN</a>) from Buy to Hold and maintained the price target of $16. Rivian Automotive shares closed at $14.87 on Tuesday. <a href="https://www.benzinga.com/quote/RIVN/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Leerink Partners analyst Daina Graybosch downgraded iTeos Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ITOS#NASDAQ">ITOS</a>) from Outperform to Market Perform and lowered the price target from $47 to $9. ITeos Therapeutics shares closed at $7.85 on Tuesday. <a href="https://www.benzinga.com/quote/ITOS/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Barclays analyst Benjamin Theurer downgraded Lavoro Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LVRO#NASDAQ">LVRO</a>) from Overweight to Underweight and lowered the price target from $5 to $1.5. Lavoro shares closed at $2.44 on Tuesday. <a href="https://www.benzinga.com/quote/LVRO/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Loop Capital analyst Laura Champine downgraded Wayfair Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/W#NYSE">W</a>) from Hold to Sell and announced a $35 price target. Wayfair shares closed at $39.01 on Tuesday. <a href="https://www.benzinga.com/quote/W/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Considering buying W stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="589" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14080939/image-160-1024x589.png" alt="" class="wp-image-914889" style="width:648px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14080939/image-160-1024x589.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14080939/image-160-300x173.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14080939/image-160-768x442.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14080939/image-160.png 1116w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/05/45375319/jim-cramer-ok-harrow-recommends-buying-this-energy-stock">Jim Cramer Is &#8216;OK&#8217; With Harrow, Recommends Buying This Energy Stock</a> </li>
</ul>
Photo via Shutterstock

Pre-Market Outlook

Trading Ideas

ITOS

LVRO

RIVN

This Wayfair Analyst Turns Bearish; Here Are Top 4 Downgrades For Wednesday

AFCG

UPDAT|E: Advanced Flower Capital Q1 Adj. EPS $0.21 Misses $0.25 Estimate, Net Interest Income $6.64M Miss $7.61M Estimate

COIN rises over 20 points after Alert from TradePulse
<figure class="wp-block-image size-large"><img decoding="async" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/13204515/Screenshot-2025-05-13-at-4.38.28%E2%80%AFPM-1010x1024.png" alt="" class="wp-image-12908" /></figure>
CoinBase Global (COIN)&nbsp;today experienced a Power Inflow, a significant event for those who follow where smart money goes and value order flow analytics in their trading decisions.&nbsp;
Today, at&nbsp;10:46 AM on May 13th, a significant trading signal occurred for&nbsp;CoinBase Global Inc., (COIN)&nbsp;as it demonstrated a Power Inflow at a price of&nbsp;$240.74. This indicator is crucial for traders who want to know directionally where institutions and so-called "smart money" moves in the market. They see the value of utilizing order flow analytics to guide their trading decisions. The Power Inflow points to a possible uptrend in Coinbase's stock, marking a potential entry point for traders looking to capitalize on the expected upward movement. Traders with this signal closely watch for sustained momentum in Coinbase's stock price, interpreting this event as a bullish sign.
Signal description
Order flow analytics, aka transaction or market flow analysis, separate and study both the retail and institutional volume rate of orders (flow). It involves analyzing the flow of buy and sell orders, along with size, timing, and other associated characteristics and patterns, to gain insights and make more informed trading decisions.&nbsp;This particular indicator is interpreted as a bullish signal by active traders.&nbsp;
The Power Inflow occurs within the first two hours of the market open and generally signals the trend that helps gauge the stock's overall direction, powered by institutional activity in the stock, for the remainder of the day.&nbsp;
By incorporating order flow analytics into their trading strategies, market participants can better interpret market conditions, identify trading opportunities, and potentially improve their trading performance. But let's not forget that while watching smart money flow can provide valuable insights, it is crucial to incorporate effective risk management strategies to protect capital and mitigate potential losses. Employing a consistent and effective risk management plan helps traders navigate the uncertainties of the market in a more controlled and calculated manner, increasing the likelihood of long-term success
If you want to stay updated on the latest options trades for&nbsp;COIN,&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>&nbsp;gives you real-time options trades alerts.&nbsp;
<a href="https://benzinga.com/apis?_gl=1&#x2A;1hlgn5i&#x2A;_ga&#x2A;MTY1NjE2NTYxMi4xNzE0NzQ4MTAy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDc0ODEwMi4xLjEuMTcxNDc0ODQyOC4wLjAuMA..">Market News and Data brought to you by Benzinga APIs</a>&nbsp;and include firms, like&nbsp;<a href="https://tradepulse.net/?utm_source=benzinga&amp;utm_medium=article&amp;utm_campaign=brand_awareness_apr2025">https://tradepulse.net/?utm_source=benzinga&amp;utm_medium=article&amp;utm_campaign=brand_awareness_apr2025</a>, which are responsible for parts of the data within this article.
&#xA9; 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved
After Market Close UPDATE:
The price at the time of the Power Inflow was $240.74. The returns on the High price ($260.42) and Close price ($256.90) after the Power Inflow are respectively 8.2% and 6.7%. The result underlines the importance of a trading plan that includes Profit Targets and Stop Losses that reflect your risk appetite.
Results are not indicative of future results

Equities

WIIM

Technicals

Signals

Coinbase Global Rises 8.2% After Key Signal

Events

INAB

IN8bio Presents Preclinical Data From INB-619 Program

RYTM

Rhythm Pharmaceuticals Presents Data On Patients With Acquired Or Congenital Hypothalamic Obesity (N=35) Treated With Setmelanotide For Up To Nine Months In French Early-Access Program

<h3>Gainers</h3>
<ul>
<li>HWH International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HWH#NASDAQ">HWH</a>) shares increased by 34.7% to $1.63 during Wednesday's pre-market session. The market value of their outstanding shares is at $10.5 million. </li>
<li>IZEA Worldwide (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IZEA#NASDAQ">IZEA</a>) shares moved upwards by 17.46% to $2.69. The company's market cap stands at $45.6 million. As per the press release, Q1 earnings came out yesterday. </li>
<li>FingerMotion (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FNGR#NASDAQ">FNGR</a>) stock increased by 14.15% to $5.0. The market value of their outstanding shares is at $285.7 million. </li>
<li>Lendway (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LDWY#NASDAQ">LDWY</a>) stock rose 9.89% to $4.33. The market value of their outstanding shares is at $7.6 million. As per the news, the Q1 earnings report came out yesterday. </li>
<li>Haoxi Health Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HAO#NASDAQ">HAO</a>) shares rose 9.58% to $1.6. The market value of their outstanding shares is at $4.5 million. </li>
<li>Global Interactive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GITS#NASDAQ">GITS</a>) shares rose 7.33% to $1.61. The market value of their outstanding shares is at $4.2 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>TEN Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XHLD#NASDAQ">XHLD</a>) shares decreased by 33.1% to $0.92 during Wednesday's pre-market session. The company's market cap stands at $25.9 million. </li>
<li>Asset Entities (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASST#NASDAQ">ASST</a>) stock decreased by 9.89% to $5.38. The market value of their outstanding shares is at $73.4 million. </li>
<li>Surgepays (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SURG#NASDAQ">SURG</a>) stock declined by 9.23% to $3.05. The company's market cap stands at $62.2 million. As per the news, the Q1 earnings report came out yesterday. </li>
<li>Baosheng Media Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BAOS#NASDAQ">BAOS</a>) stock decreased by 6.48% to $2.5. The company's market cap stands at $3.8 million. </li>
<li>TNL Mediagene (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNMG#NASDAQ">TNMG</a>) shares fell 5.53% to $0.68. The company's market cap stands at $17.8 million. </li>
<li>BloomZ (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLMZ#NASDAQ">BLMZ</a>) shares fell 5.37% to $0.13. The market value of their outstanding shares is at $1.9 million. 
See Also: <a href="http://www.benzinga.com/money/best-communication-services-stocks/" title="www.benzinga.com/money/best-communication-services-stocks/">www.benzinga.com/money/best-communication-services-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

ASST

BAOS

BLMZ

FNGR

GITS

IZEA

LDWY

SURG

TNMG

XHLD

12 Communication Services Stocks Moving In Wednesday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Septerna (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEPN#NASDAQ">SEPN</a>) stock rose 74.9% to $11.77 during Wednesday's pre-market session. The market value of their outstanding shares is at $523.9 million. </li>
<li>Innovative Eyewear (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUCY#NASDAQ">LUCY</a>) shares rose 63.63% to $3.24. The market value of their outstanding shares is at $9.8 million. As per the news, the Q1 earnings report came out yesterday. </li>
<li>Quoin Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QNRX#NASDAQ">QNRX</a>) stock moved upwards by 51.72% to $9.65. The market value of their outstanding shares is at $198.6 million. As per the press release, Q1 earnings came out yesterday. </li>
<li>Nutex Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUTX#NASDAQ">NUTX</a>) shares increased by 14.34% to $144.0. The market value of their outstanding shares is at $782.9 million. The company's, Q1 earnings came out yesterday. </li>
<li>DBV Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DBVT#NASDAQ">DBVT</a>) stock moved upwards by 14.01% to $12.53. The company's market cap stands at $342.7 million. </li>
<li>Advanced Biomed (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADVB#NASDAQ">ADVB</a>) shares increased by 12.74% to $1.15. The company's market cap stands at $24.8 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Polyrizon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLRZ#NASDAQ">PLRZ</a>) stock fell 46.3% to $0.02 during Wednesday's pre-market session. </li>
<li>Accelerate Diagnostics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AXDX#NASDAQ">AXDX</a>) shares decreased by 29.44% to $0.06. The company's market cap stands at $1.5 million. </li>
<li>Abpro Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABP#NASDAQ">ABP</a>) stock decreased by 16.79% to $0.17. The market value of their outstanding shares is at $8.9 million. </li>
<li>EUDA Health Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EUDA#NASDAQ">EUDA</a>) shares decreased by 15.48% to $3.55. The company's market cap stands at $131.8 million. </li>
<li>GRAIL (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRAL#NASDAQ">GRAL</a>) stock fell 13.15% to $37.25. The market value of their outstanding shares is at $1.3 billion. As per the press release, Q1 earnings came out yesterday. </li>
<li>Apyx Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APYX#NASDAQ">APYX</a>) shares fell 12.03% to $1.39. The market value of their outstanding shares is at $52.5 million. As per the press release, Q1 earnings came out 4 days ago. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ADVB

APYX

AXDX

DBVT

Euda Health Holdings Limited - Ordinary Shares

EUDA

GRAL

LUCY

NUTX

PLRZ

QNRX

SEPN

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Everus Construction Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ECG#NYSE">ECG</a>) stock moved upwards by 15.7% to $59.5 during Wednesday's pre-market session. The company's market cap stands at $3.0 billion. As per the news, the Q1 earnings report came out yesterday. </li>
<li>Acuren (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/TIC#AMEX">TIC</a>) shares rose 11.73% to $12.0. The company's market cap stands at $1.4 billion. </li>
<li>Micropolis Hldgs (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MCRP#AMEX">MCRP</a>) stock rose 11.67% to $2.2. The company's market cap stands at $74.5 million. </li>
<li>KULR Technology Group (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/KULR#AMEX">KULR</a>) shares rose 7.64% to $1.69. The company's market cap stands at $404.3 million. </li>
<li>Karman Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KRMN#NYSE">KRMN</a>) stock increased by 6.59% to $42.81. The market value of their outstanding shares is at $5.6 billion. As per the press release, Q1 earnings came out yesterday. </li>
<li>Primega Group Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PGHL#NASDAQ">PGHL</a>) shares moved upwards by 6.18% to $0.54. The company's market cap stands at $14.2 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Hydrofarm Holdings Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HYFM#NASDAQ">HYFM</a>) stock fell 21.1% to $2.61 during Wednesday's pre-market session. The company's market cap stands at $12.1 million. As per the news, the Q1 earnings report came out yesterday. </li>
<li>Ming Shing Group Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSW#NASDAQ">MSW</a>) stock declined by 11.95% to $5.6. The company's market cap stands at $72.6 million. </li>
<li>Northann (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/NCL#AMEX">NCL</a>) stock fell 10.47% to $0.56. The market value of their outstanding shares is at $31.0 million. </li>
<li>Aqua Metals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AQMS#NASDAQ">AQMS</a>) stock fell 9.53% to $0.94. The market value of their outstanding shares is at $8.3 million. As per the news, the Q1 earnings report came out 4 days ago. </li>
<li>WANG &amp; LEE Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WLGS#NASDAQ">WLGS</a>) stock declined by 7.96% to $0.29. The company's market cap stands at $6.1 million. </li>
<li>Centuri Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTRI#NYSE">CTRI</a>) stock fell 7.75% to $18.57. The company's market cap stands at $1.6 billion. The company's, Q1 earnings came out 2 days ago. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AQMS

CTRI

HYFM

KRMN

KULR

MCRP

Nuveen Insured California Premium Fund Ii

PGHL

WLGS

12 Industrials Stocks Moving In Wednesday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Super Micro Computer (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>) shares rose 15.6% to $44.94 during Wednesday's pre-market session. The company's market cap stands at $26.8 billion. </li>
<li>Radcom (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RDCM#NASDAQ">RDCM</a>) stock increased by 14.31% to $14.69. The company's market cap stands at $235.4 million. As per the news, the Q1 earnings report came out today. </li>
<li>Digital Ally (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DGLY#NASDAQ">DGLY</a>) stock moved upwards by 11.27% to $0.04. </li>
<li>Diginex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DGNX#NASDAQ">DGNX</a>) shares rose 9.09% to $84.0. The market value of their outstanding shares is at $1.9 billion. </li>
<li>Ondas Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONDS#NASDAQ">ONDS</a>) shares rose 8.83% to $0.94. The company's market cap stands at $125.4 million. </li>
<li>Red Cat Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RCAT#NASDAQ">RCAT</a>) stock moved upwards by 8.62% to $6.93. The company's market cap stands at $627.2 million. As per the news, the Q1 earnings report came out today. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>X3 Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XTKG#NASDAQ">XTKG</a>) shares declined by 21.3% to $1.66 during Wednesday's pre-market session. The company's market cap stands at $22.7 million. </li>
<li>Aurora Innovation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUR#NASDAQ">AUR</a>) stock decreased by 19.41% to $5.9. The market value of their outstanding shares is at $10.4 billion. As per the press release, Q1 earnings came out 4 days ago. </li>
<li>Gryphon Digital Mining (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRYP#NASDAQ">GRYP</a>) shares fell 15.63% to $1.08. The company's market cap stands at $74.8 million. </li>
<li>Actelis Networks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASNS#NASDAQ">ASNS</a>) stock fell 14.56% to $0.68. The company's market cap stands at $5.8 million. As per the press release, Q1 earnings came out yesterday. </li>
<li>Endava (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAVA#NYSE">DAVA</a>) stock declined by 12.38% to $18.76. The market value of their outstanding shares is at $1.1 billion. As per the press release, Q3 earnings came out today. </li>
<li>Taoping (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TAOP#NASDAQ">TAOP</a>) shares decreased by 12.33% to $0.24. The market value of their outstanding shares is at $3.2 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ASNS

DAVA

DGLY

DGNX

GRYP

ONDS

RCAT

RDCM

SMCI

TAOP

XTKG

12 Information Technology Stocks Moving In Wednesday's Pre-Market Session

NWTN

NWTN Appointed Benjamin Bin Zhai As CEO; Succeeds Alan Wu

Smart shopping comes to Perplexity as PayPal powers intelligent, in-flow shopping via Agentic AI
SAN JOSE, Calif., May 14, 2025 /PRNewswire/ -- Perplexity today announced that it has partnered with&nbsp;PayPal to power agentic commerce across its Perplexity Pro platform. Starting this summer in the U.S., consumers can check out instantly with PayPal or Venmo when they&nbsp;ask Perplexity to find products, book travel, or buy tickets.

PYPL

Perplexity Selects PayPal To Power Agentic Commerce; Consumers Can Check Out Instantly With PayPal Or Venmo When They Ask Perplexity To Find Products, Book Travel, Or Buy Tickets

DIOD

Diodes Incorporated Appoints Gary Yu As CEO

<a href="https://www.globenewswire.com/Tracker?data=UP_T1SAJbp4bd_y2ohPRJO--NlSMgc77QKeSg7QsiqQobdwB7nokQrK_cyQi0qwZa_-KdB7O4qtTv0paKjZ-2A==">Viasat Inc.&nbsp;</a>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSAT#NASDAQ">VSAT</a>), a global leader in satellite communications (SATCOM), today announced it has selected Blue Origin as its launch mission partner to support Viasat's demonstration of its <a href="https://www.globenewswire.com/Tracker?data=tYHi7wAu6cq9foTUHf9Q1Mn6rrppd6mn1yKBmnGgXWqwQ2Nw357LlkxwSaWF7gFg3C3scG5i5gy76tNZd24qIg8qFytCLYexhp95_XAoEU4=">InRange</a> launch telemetry relay service as part of its work with NASA's Communications Services Project (CSP). Viasat's Space and Mission Systems team, part of the company's Defense and Advanced Technologies (DAT) segment, will work with Blue Origin across two future launches to integrate the user terminal and InRange solution on the New Glenn launch vehicle to showcase this innovative space-based launch communications capability. Blue Origin successfully launched the first New Glenn rocket on January 16, 2025.

VSAT

Viasat Selects Blue Origin As Launch Mission Partner To Support Viasat's Demonstration Of InRange Launch Telemetry Relay Service As Part Of Work With NASA's CSP

Preclinical data demonstrate ATYR0101's unique anti-fibrotic mechanism through interaction with LTBP-1.
ATYR0101 to be showcased in oral presentation at the American Thoracic Society (ATS) 2025 Respiratory Innovation Summit.
SAN DIEGO, May 14, 2025 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATYR#NASDAQ">ATYR</a>) ("aTyr" or the "Company"), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform, today announced that it has advanced its next investigational new drug (IND) candidate, ATYR0101, which has been selected to be showcased in an oral presentation at the American Thoracic Society (ATS) 2025 Respiratory Innovation Summit, which is scheduled to take place May 16 – 17, 2025, in San Francisco, CA.
The presentation will feature preclinical data generated to date for ATYR0101, a fusion protein derived from a proprietary extracellular domain of aspartyl-tRNA synthetase (DARS) that binds to latent transforming growth factor beta binding protein 1 (LTBP-1) to induce cell death of myofibroblasts, which are key cells responsible for driving the progression of fibrosis.

ATYR

aTyr Pharma Advances ATYR0101 To IND Candidate Stage For Pulmonary Fibrosis; Preclinical Data Demonstrate ATYR0101's Unique Anti-fibrotic Mechanism Through Interaction With LTBP-1

Western Digital And Ingrasys Collaborate On Top-of-Rack Switch With Embedded Storage

Press Releases

Repare Therapeutics to Host Webcast to Report Data from the Lunresertib and Camonsertib Combination Phase 1 MYTHIC Clinical Trial

Repare Therapeutics Announces Positive Results of the Lunresertib and Camonsertib Combination from the MYTHIC Phase 1 Gynecologic Expansion Clinical Trial

Opinion

How Cutting-Edge Immunotherapies Are Redefining Cancer Treatment Options

Repare Therapeutics Announces Portfolio Re-Prioritization, Partnering Initiatives and Cost Reductions

Repare Therapeutics Provides Business and Clinical Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Repare Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Repare Therapeutics Announces Leadership Transitions

Repare Therapeutics Announces Six Abstracts Accepted for Presentation at AACR Annual Meeting 2025

Repare Therapeutics Announces Out-Licensing of its Discovery Platforms to DCx Biotherapeutics

Newly Launched DCx Biotherapeutics In-Licenses Discovery Platforms and Retains Talent and Infrastructure From Repare Therapeutics to Accelerate Development of Multi-Modal Antibody Drug Conjugates

Comments

Repare Therapeutics

Repare Therapeutics (RPTX) Options

Repare Therapeutics (NASDAQ:RPTX) Stock, Chaîne d'Options

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL